Advertisement

Spinal Tech

Advertisement

Medtronic's cranial and spine technologies division saw a slight revenue decrease in the second quarter of the 2022 fiscal year, and the company earned $7.84 billion in total revenue.

Johnson & Johnson on Nov. 12 announced its plan to split into two separate companies — one focusing on medical devices and drugs, and the other focusing on consumer health products.

The FDA's Breakthrough Devices Program is designed to accelerate the development, assessment and review of medical devices that provide effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.

Advertisement